As of Feb 23
| +0.51 / +3.05%|
The 3 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 16.00, with a high estimate of 16.50 and a low estimate of 16.00. The median estimate represents a -7.19% decrease from the last price of 17.24.
The current consensus among 5 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.